Nanoparticles laden in situ gel of levofloxacin for enhanced ocular retention. (17th September 2013)

• Record Type: Journal Article
• Authors: Gupta, Himanshu; Aqil, M.; Khar, R. K.; Ali, Asgar; Bhatnagar, Aseem; Mittal, Gaurav
• Is Part Of: Drug delivery. Volume 20:Number 7(2013:Oct.)
• Page Start: 306
• Page End: 309
• Publication Date: 2013-09-17
• Subjects: Gamma scintigraphy -- in situ gel -- levofloxacin -- nanoparticle -- nanoparticle laden in situ gel -- ocular -- PLGA; Drug delivery systems -- Periodicals; Drug targeting -- Periodicals; 615.05
• DOI: 10.3109/10717544.2013.838712
• Languages: English
• ISSNs: 1071-7544

Abstract

Abstract: Availability of proper concentration of medicament on to the corneal surface is a challenging task. Many novel formulations, i.e. hydrogels, nanoparticles, ocuserts, etc. had been tested to improve ocular bioavailability, out of which our group found, in situ gel and polymeric nanoparticle are the most interesting approach to achieve ocular retention. We found that in situ gel stay only for 12 h and poly(lactic-co-glycolic acid (PLGA) nanoparticles are non mucoadhesive in nature so we try to combine both these formulations and termed it as "Nanoparticle laden in situ gel". Here we prepare nanoparticle laden in situ gel containing levofloxacin encapsulated PLGA nanoparticle, incorporated in chitosan in situ gel and evaluated its ocular retention by gamma scintigraphy in rabbits. The observations of acquired gamma camera images showed good retention over the entire precorneal area. From static and dynamic gamma scintigraphy evaluation, we can be interpret that developed nanoparticle laden in situ gel formulation cleared at a very slow rate and remained at corneal surface for longer duration than marketed formulation, in situ gel and nanosuspension alone.